The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

Mohammad Alzrigat, Alba Atienza Párraga, Muntasir Mamun Majumder, Anqi Ma, Jian Jin, Anders Österborg, Hareth Nahi, Kenneth Nilsson, Caroline A. Heckman, Fredrik Öberg, Antonia Kalushkova, Helena Jernberg-Wiklund

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftOncotarget
Volym8
Utgåva61
Sidor (från-till)103731-103743
Antal sidor13
ISSN1949-2553
DOI
StatusPublicerad - 2017
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3111 Biomedicinska vetenskaper

Citera det här

Alzrigat, Mohammad ; Párraga, Alba Atienza ; Majumder, Muntasir Mamun ; Ma, Anqi ; Jin, Jian ; Österborg, Anders ; Nahi, Hareth ; Nilsson, Kenneth ; Heckman, Caroline A. ; Öberg, Fredrik ; Kalushkova, Antonia ; Jernberg-Wiklund, Helena. / The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains. I: Oncotarget. 2017 ; Vol. 8, Nr. 61. s. 103731-103743.
@article{93bc1c632f3b4c1682f6b9c521930085,
title = "The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains",
keywords = "3111 Biomedicine",
author = "Mohammad Alzrigat and P{\'a}rraga, {Alba Atienza} and Majumder, {Muntasir Mamun} and Anqi Ma and Jian Jin and Anders {\"O}sterborg and Hareth Nahi and Kenneth Nilsson and Heckman, {Caroline A.} and Fredrik {\"O}berg and Antonia Kalushkova and Helena Jernberg-Wiklund",
year = "2017",
doi = "10.18632/oncotarget.21909",
language = "English",
volume = "8",
pages = "103731--103743",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "61",

}

Alzrigat, M, Párraga, AA, Majumder, MM, Ma, A, Jin, J, Österborg, A, Nahi, H, Nilsson, K, Heckman, CA, Öberg, F, Kalushkova, A & Jernberg-Wiklund, H 2017, 'The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains', Oncotarget, vol. 8, nr. 61, s. 103731-103743. https://doi.org/10.18632/oncotarget.21909

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains. / Alzrigat, Mohammad ; Párraga, Alba Atienza; Majumder, Muntasir Mamun; Ma, Anqi ; Jin, Jian ; Österborg, Anders ; Nahi, Hareth ; Nilsson, Kenneth ; Heckman, Caroline A.; Öberg, Fredrik ; Kalushkova, Antonia ; Jernberg-Wiklund, Helena.

I: Oncotarget, Vol. 8, Nr. 61, 2017, s. 103731-103743.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

AU - Alzrigat, Mohammad

AU - Párraga, Alba Atienza

AU - Majumder, Muntasir Mamun

AU - Ma, Anqi

AU - Jin, Jian

AU - Österborg, Anders

AU - Nahi, Hareth

AU - Nilsson, Kenneth

AU - Heckman, Caroline A.

AU - Öberg, Fredrik

AU - Kalushkova, Antonia

AU - Jernberg-Wiklund, Helena

PY - 2017

Y1 - 2017

KW - 3111 Biomedicine

U2 - 10.18632/oncotarget.21909

DO - 10.18632/oncotarget.21909

M3 - Article

VL - 8

SP - 103731

EP - 103743

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 61

ER -